Literature DB >> 21619919

Effects of Panax notoginseng saponins on proliferation and apoptosis of vascular smooth muscle cells.

Li Xu1, Jun-Tian Liu, Na Liu, Pei-Pei Lu, Xiao-Ming Pang.   

Abstract

AIM OF THE STUDY: Atherosclerosis is a common cardiovascular disease, and linked with the development of many cardiovascular complications, such as myocardial ischemia and stroke. Although pathogenesis of atherosclerosis is not completely elucidated, increasing evidence has demonstrated that abnormal proliferation of vascular smooth muscle cells (VSMCs) plays an important role in formation of atherosclerosis. Previous studies showed that saponins from Panax notoginseng (PNS) possess anti-atherosclerotic properties. However, the mechanism of PNS against atherosclerosis is not well understood. Therefore, the present study observed the effects of PNS on proliferation and apoptosis of VSMCs.
MATERIALS AND METHODS: Rat VSMCs were cultured, and platelet-derived growth factor (PDGF) was used to stimulate cell proliferation. The viability of VSMCs was assessed with the MTT method. VSMCs apoptosis was detected by flow cytometry. Expressions of apoptosis related protein p53, Bax, caspase-3 and Bcl-2 were determined using Western blot.
RESULTS: Pretreatment of the cells with PNS (200, 400, 800 μg/mL) significantly inhibited proliferation of PDGF-stimulated VSMCs, and induced apoptosis of the proliferated VSMCs in a concentration-dependent way. Western blot analysis showed that PNS upregulated expressions of pro-apoptotic protein p53, Bax and caspase-3, downregulated expression of anti-apoptotic protein Bcl-2, and enlarged Bax/Bcl-2 ratio in the proliferated VSMCs induced by PDGF.
CONCLUSIONS: This study demonstrates that PNS both inhibits VSMCs proliferation and induces VSMCs apoptosis through upregulating p53, Bax, caspase-3 expressions and downregulating Bcl-2 expression, which constitute the pharmacological basis of its anti-atherosclerotic action.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619919     DOI: 10.1016/j.jep.2011.05.020

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Ginsenoside Rg1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of p38.

Authors:  Mengxiao Zheng; Meiping Zhao; Lanlan Tang; Congcong Zhang; Longsheng Song; Wantie Wang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

2.  Exploring mechanisms of Panax notoginseng saponins in treating coronary heart disease by integrating gene interaction network and functional enrichment analysis.

Authors:  Gui Yu; Jie Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

3.  Protective effect of Panax ginseng against serum biochemical changes and apoptosis in kidney of rats treated with gentamicin sulphate.

Authors:  Yildiray Kalkan; Kubra Asena Terim Kapakin; Adem Kara; Tennur Atabay; Ali Karadeniz; Nejdet Simsek; Emre Karakus; Ismail Can; Serap Yildirim; Seckin Ozkanlar; Emin Sengul
Journal:  J Mol Histol       Date:  2012-04-10       Impact factor: 2.611

4.  American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway.

Authors:  Qi Wu; Wenjuan Wang; Siying Li; Prakash Nagarkatti; Mitzi Nagarkatti; Anthony Windust; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  J Ethnopharmacol       Date:  2012-10-04       Impact factor: 4.360

5.  Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway.

Authors:  Lulu Pan; Yuanhai Zhang; Jiacheng Lu; Zhimin Geng; Lianhong Jia; Xing Rong; Zhenquan Wang; Qifeng Zhao; Rongzhou Wu; Maoping Chu; Chunxiang Zhang
Journal:  J Cardiovasc Transl Res       Date:  2015-11-02       Impact factor: 4.132

Review 6.  Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

7.  Quality Assessment of Panax notoginseng from Different Regions through the Analysis of Marker Chemicals, Biological Potency and Ecological Factors.

Authors:  Hai-Zhu Zhang; Da-Hui Liu; Ding-Kun Zhang; Yan-Hui Wang; Gang Li; Gui-Lin Yan; Li-Juan Cao; Xiao-He Xiao; Lu-Qi Huang; Jia-Bo Wang
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

8.  Panax notoginseng Saponins Attenuate Phenotype Switching of Vascular Smooth Muscle Cells Induced by Notch3 Silencing.

Authors:  Nan Liu; Dazhi Shan; Ying Li; Hui Chen; Yonghong Gao; Yonghua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

Review 9.  Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.

Authors:  Haiping Zhao; Ziping Han; Guangwen Li; Sijia Zhang; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

10.  Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation, migration and neointimal hyperplasia through PI3K/Akt signaling.

Authors:  Haihong Fang; Shilin Yang; Yingying Luo; Cheng Zhang; Yi Rao; Renjing Liu; Yulin Feng; Jun Yu
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.